Back to Search
Start Over
Primary Sclerosing Cholangitis-Associated Cholangiocarcinoma Demonstrates High Intertumor and Intratumor Heterogeneity
- Source :
- Clinical and Translational Gastroenterology, Clinical and Translational Gastroenterology, 12(10). Nature Publishing Group, Clinical and translational gastroenterology, 12(10). Nature Publishing Group
- Publication Year :
- 2021
-
Abstract
- Introduction Intertumor and intratumor heterogeneity may explain the diagnostic challenge and limited efficacy of chemotherapy for primary sclerosing cholangitis-associated cholangiocarcinoma (PSC-CCA). In this study, tumor heterogeneity was assessed through p53 and p16 protein expression analysis and next-generation sequencing (NGS) of TP53 and CDKN2A genetic alterations in PSC-associated CCA. Methods Formalin-fixed paraffin-embedded tissue samples from resection material of patients with PSC-CCA or patients with PSC diagnosed with biliary dysplasia were selected. Sections with CCA and foci with dysplastic epithelium were identified by 2 independent gastrointestinal pathologists. Immunohistochemical evaluation of p53 and p16 protein expression and NGS of TP53 and CDKN2A genetic alterations were performed. Results A total of 49 CCA and 21 dysplasia samples were identified in the resection specimens of 26 patients. P53 protein expression showed loss of expression, wild type, and overexpression in 14%, 63%, and 23% CCA and in 19%, 62%, and 19% dysplasia samples, respectively. P16 protein expression showed negative, heterogeneous, and positive results in 31%, 57%, and 12% CCA and in 33%, 53%, and 14% dysplasia samples, respectively. NGS showed high intertumor and intratumor heterogeneity of TP53 mutations and CDKN2A loss. Nearly 70% of the samples with a TP53 missense mutation demonstrated p53 overexpression, whereas all samples with a TP53 nonsense mutation demonstrated loss of p53 protein expression. Discussion PSC-associated CCA is characterized by high intertumor and intratumor heterogeneity of both p53/p16 protein expression and genetic alterations in TP53/CDKN2A, indicating that these tumors consist of multiple subclones with substantially different genetic makeup. The high intertumor and intratumor heterogeneity in PSC-CCA should be acknowledged during the development of diagnostic and therapeutic strategies.
- Subjects :
- Adult
Male
Pathology
medicine.medical_specialty
endocrine system diseases
medicine.medical_treatment
Nonsense mutation
Cholangitis, Sclerosing
Mutation, Missense
Article
Primary sclerosing cholangitis
Cholangiocarcinoma
CDKN2A
medicine
Missense mutation
Humans
Cyclin-Dependent Kinase Inhibitor p16
Chemotherapy
business.industry
Genes, p16
Biliary
Gastroenterology
High-Throughput Nucleotide Sequencing
medicine.disease
Genes, p53
Immunohistochemistry
Epithelium
digestive system diseases
medicine.anatomical_structure
Bile Duct Neoplasms
Dysplasia
Codon, Nonsense
Female
Tumor Suppressor Protein p53
business
Subjects
Details
- Language :
- English
- ISSN :
- 2155384X
- Volume :
- 12
- Issue :
- 10
- Database :
- OpenAIRE
- Journal :
- Clinical and Translational Gastroenterology
- Accession number :
- edsair.doi.dedup.....3c92655807a66571f0bab30b98385e42